Mark Avigan

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas16.3%
• Instituto de Investigación Biomédica de Málaga16.3%
• Inserm10.5%
• National Cancer Institute7%
• University of North Carolina at Chapel Hill6.3%
• National Institutes of Health6%
• Other37.7%

Fields

• Medicine41.9%
• Biochemistry, Genetics and Molecular Biology26.1%
• Pharmacology, Toxicology and Pharmaceutics26.1%
• Immunology and Microbiology2.3%
• Agricultural and Biological Sciences0.9%
• Engineering0.4%
• Other2.3%

Topics

• Drug-Induced Hepatotoxicity and Protection23.6%
• Liver Disease Diagnosis and Treatment11.1%
• Pharmacogenetics and Drug Metabolism8.6%
• Liver Diseases and Immunity7.5%
• RNA Research and Splicing6.9%
• Cancer Immunotherapy and Biomarkers6.7%
• Other35.6%